This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Korea Research Institute of Bioscience and Biotechnology. Active years: 2009-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2011
Title: Sejeong Oh: Innovator in Cancer Diagnosis
Introduction: Sejeong Oh is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer diagnosis through his innovative research and patented technologies. With a total of two patents, his work focuses on the critical area of tumorigenesis and metastasis.
Latest Patents: Sejeong Oh's latest patents include a method for the diagnosis of cancers by measuring the changes of glycosylation of proteins related to tumorigenesis and metastasis. This invention also encompasses a diagnostic kit that utilizes this method. The approach is particularly effective for diagnosing various types of cancers, including colon cancer, stomach cancer, lung cancer, and liver cancer. The sensitivity of this method allows for early detection, which is crucial in improving patient outcomes.
Career Highlights: Sejeong Oh is affiliated with the Korea Research Institute of Bioscience and Biotechnology, where he conducts his research. His work has garnered attention for its potential impact on cancer diagnostics and treatment strategies.
Collaborations: Some of his notable coworkers include Jeong Heon Ko and Soo Young Hwang, who contribute to the collaborative efforts in advancing cancer research.
Conclusion: Sejeong Oh's innovative work in cancer diagnosis exemplifies the importance of research and development in the medical field. His contributions are paving the way for more effective diagnostic methods that can save lives.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile